No Data
No Data
Neurocrine Biosciences Insider Sold Shares Worth $9,197,550, According to a Recent SEC Filing
Neurocrine Biosciences(NBIX.US) Officer Sells US$9.2 Million in Common Stock
$Neurocrine Biosciences(NBIX.US)$ Officer Gano Kyle sold 65,000 shares of common stock on Jan 15, 2025 at an average price of $141.5008 for a total value of $9.2 million.Source: Announcement What is
Oppenheimer Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Maintains Target Price $192
J.P. Morgan Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating
Positive Growth Prospects for Neurocrine Biosciences Driven by Crenessity Launch and Strategic Patient Accessibility Initiatives
Neurocrine Is Maintained at Buy by UBS